Opdivo (nivolumab)

pCPA File Number: 21086
Negotiation Status:
Negotiations were not pursued
Indication(s):
hepatocellular carcinoma
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CADTH Project Number:
pCODR 10134
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: